The most notable strategic choice is prioritising myasthenia gravis (MG) and Sjögren's disease as lead indications while ...
Going into 2026, biotech company Ladder Bio is embracing a new identity.
Meanwhile, during the WSJ event in Davos this week, Pfizer’s Bourla also took aim at the Trump administration’s moves to cut ...
Biohaven has suffered a few setbacks in recent months, including an FDA rejection and a missed $150 million benchmark payment ...
For the second year in a row, flashes of pink cut through the sea of navy, gray and black that flooded San Francisco’s Union ...
Shortly after joining OnlyFans in early January 2026, Piper Rockelle told PEOPLE that she thrives off the "hate" she receives ...
As biotechs faced investors at the J.P. Morgan Healthcare Conference this week, they emphasized agreement with the FDA on ...
The market is poised for growth due to cost-competitive expansions in Asia-Pacific, net-zero building mandates in North America & Europe, and rising demand in rigid foams for energy-efficient ...
I set out to see how six leading chatbots handled trick questions, and every single one confidently hallucinated. Each ...
He concluded that if the government can provide “Green Grid” certification to protect traditional textile exports and ...
The original Grandma Liu's in Richmond and the newer JOJO Pot in West Vancouver (which opened in May 2025) are both still ...
Regenerative medicine is driving breakthroughs, the market is pivoting from niche insurance to essential healthcare. While ...